,,,,,Dependent Variable,CVC investment,,,,
,10 -,year,5 - year,3 - year,1 - year,10 -,year,5 - year,3 - year,1 - year
Variables,Model 1,Model 2,Model 3,Model 4,Model 5,Model 6,Model 7,Model 8,Model 9,Model 10
Main effect,,,,,,,,,,
Spinout,-0.02,,,,,-0.02,,,,
,( 0.07 ),,,,,( 0.07 ),,,,
Spinout with high TOSP,,-0.43 ***,-0.36 ***,-0.52 ***,-0.46 ***,,-0.44 ***,-0.37 ***,-0.52 ***,-0.46 ***
,,( 0.12 ),( 0.13 ),( 0.14 ),( 0.15 ),,( 0.13 ),( 0.14 ),( 0.15 ),( 0.15 )
Spinout with low TOSP,,0.14 *,0.16 **,0.10,0.08,,0.14 *,0.15 *,0.10,0.07
,,( 0.07 ),( 0.08 ),( 0.08 ),( 0.10 ),,( 0.07 ),( 0.08 ),( 0.08 ),( 0.10 )
Control variables,,,,,,,,,,
Venture patent count,0.18 ***,0.18 ***,0.18 ***,0.18 ***,0.18 ***,0.19 ***,0.19 ***,0.19 ***,0.20 ***,0.20 ***
,( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 ),( 0.03 )
Venture age,0.02 *,0.02 **,0.02 *,0.02 **,0.02 **,0.02 *,0.02 **,0.02 *,0.02 **,0.02 **
,( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 )
Founder PhD or MD,-0.02,-0.03,-0.03,-0.03,-0.03,-0.01,-0.03,-0.02,-0.02,-0.02
,( 0.07 ),( 0.06 ),( 0.06 ),( 0.06 ),( 0.06 ),( 0.07 ),( 0.07 ),( 0.07 ),( 0.07 ),( 0.06 )
Number of founders,-0.02,-0.00,-0.01,-0.00,-0.01,-0.02,-0.00,-0.01,-0.00,-0.01
,( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 ),( 0.05 )
Manufacturing resource need,0.09,0.32,0.19,0.13,0.11,0.26,0.49,0.34,0.29,0.27
,( 0.88 ),( 0.90 ),( 0.89 ),( 0.89 ),( 0.89 ),( 0.93 ),( 0.94 ),( 0.94 ),( 0.94 ),( 0.94 )
Marketing resource need,2.81,2.02,2.45,2.44,2.66,2.56,1.81,2.25,2.23,2.45
,( 5.35 ),( 5.44 ),( 5.31 ),( 5.31 ),( 5.39 ),( 5.48 ),( 5.56 ),( 5.44 ),( 5.44 ),( 5.51 )
Corporate investor patent count,-0.00,-0.00,-0.00,-0.00,-0.00,-0.03,-0.03,-0.04,-0.03,-0.03
,( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.09 ),( 0.09 ),( 0.09 ),( 0.09 ),( 0.09 )
Corporate investor new product,0.08 ***,0.08 ***,0.08 ***,0.08 ***,0.08 ***,0.11 *,0.12 *,0.12 *,0.12 *,0.12 *
,( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.07 ),( 0.07 ),( 0.07 ),( 0.07 ),( 0.07 )
Corporate investor R & D intensity,0.58 **,0.58 **,0.57 **,0.58 **,0.57 **,-0.11,-0.13,-0.12,-0.12,-0.12
,( 0.24 ),( 0.24 ),( 0.24 ),( 0.24 ),( 0.24 ),( 0.41 ),( 0.41 ),( 0.41 ),( 0.41 ),( 0.41 )
Corporate investor patent infringement,0.00,0.00,0.00,0.00,0.00,-0.00,-0.00,-0.00,-0.00,-0.00
,( 0.00 ),( 0.00 ),( 0.00 ),( 0.00 ),( 0.00 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 ),( 0.01 )
Corporate investor size,-0.03,-0.03,-0.03,-0.03,-0.03,-0.03,-0.03,-0.03,-0.03,-0.03
,( 0.04 ),( 0.05 ),( 0.05 ),( 0.04 ),( 0.04 ),( 0.10 ),( 0.10 ),( 0.10 ),( 0.10 ),( 0.10 )
Corporate investor cash,0.09 **,0.10 ***,0.09 **,0.09 **,0.09 **,0.02,0.03,0.03,0.02,0.02
,( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 ),( 0.04 )
Corporate investor financial orientation,-0.34 **,-0.34 **,-0.33 **,-0.34 **,-0.33 **,-0.61 **,-0.62 **,-0.62 **,-0.63 **,-0.62 **
,( 0.14 ),( 0.14 ),( 0.14 ),( 0.14 ),( 0.14 ),( 0.27 ),( 0.27 ),( 0.27 ),( 0.27 ),( 0.27 )
Corporate investor strategic orientation,3.02 ***,2.99 ***,2.99 ***,3.01 ***,3.02 ***,-1.25,-1.21,-1.25,-1.24,-1.23
,( 0.69 ),( 0.70 ),( 0.70 ),( 0.69 ),( 0.69 ),( 1.46 ),( 1.47 ),( 1.47 ),( 1.47 ),( 1.46 )
Technological overlap between venture,0.63 ***,0.68 ***,0.67 ***,0.66 ***,0.66 ***,0.25 *,0.31 **,0.30 **,0.28 **,0.28 **
and corporate investor,( 0.12 ),( 0.12 ),( 0.12 ),( 0.12 ),( 0.12 ),( 0.14 ),( 0.14 ),( 0.14 ),( 0.14 ),( 0.14 )
Cross - citation between venture and,1.77 ***,1.66 ***,1.67 ***,1.70 ***,1.69 ***,1.68 ***,1.56 **,1.54 **,1.57 **,1.57 **
corporate investor,( 0.59 ),( 0.61 ),( 0.61 ),( 0.61 ),( 0.59 ),( 0.61 ),( 0.64 ),( 0.64 ),( 0.64 ),( 0.62 )
Geographic distance between venture and,-0.02,-0.01,-0.02,-0.02,-0.02,-0.02,-0.02,-0.02,-0.02,-0.02
corporate investor,( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 ),( 0.02 )
